Evidence mapPaperPMID 36940317Full record

ReviewDiabetes2023

Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.

Teresa L Mastracci, Minoti Apte, Laufey T Amundadottir, Alexandra Alvarsson, Steven Artandi, Melena D Bellin, Ernesto Bernal-Mizrachi, Alejandro Caicedo, Martha Campbell-Thompson, Zobeida Cruz-Monserrate and 24 more

Erratum issuedAbstract readConference ProceedingsReview
In one paragraph

Review in Diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Teresa L MastracciDepartment of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN.ORCID 0000-0003-1956-1951
Minoti ApteFaculty of Medicine and Health, University of New South Wales, Sydney, Australia.
Laufey T AmundadottirNational Cancer Institute, National Institutes of Health, Rockville, MD.
Alexandra AlvarssonDiabetes, Obesity, and Metabolism Institute, Mount Sinai Hospital, New York, NY.
Steven ArtandiDepartment of Internal Medicine, Stanford University, Stanford, CA.
Melena D BellinDepartments of Pediatrics and Surgery, University of Minnesota Medical School, Minneapolis, MN.
Ernesto Bernal-MizrachiDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Alejandro CaicedoDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
Martha Campbell-ThompsonDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
Zobeida Cruz-MonserrateDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
Abdelfattah El OuaamariDepartment of Medicine, Rutgers, The State University of New Jersey, New Brunswick, NJ.
Kyle J GaultonDepartment of Pediatrics, University of California San Diego, La Jolla, CA.
Andrea GeiszDepartment of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA.
Mark O GoodarziDivision of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA.
Manami HaraDepartment of Medicine, The University of Chicago, Chicago, IL.
Rebecca L Hull-MeichleDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA.
Alexander KlegerInstitute of Molecular Oncology and Stem Cell Biology, Ulm University, Ulm, Germany.
Alison P KleinDepartment of Pathology and Medicine, Johns Hopkins School of Medicine, Baltimore MD.
Janel L KoppDepartment of Cellular & Physiological Sciences, The University of British Columbia, Vancouver, Canada.
Rohit N KulkarniDepartment of Medicine, Harvard Medical School, Boston, MA.
Mandar D MuzumdarDepartments of Genetics and Internal Medicine (Oncology), Yale University School of Medicine, New Haven, CT.
Anjaparavanda P NarenDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Scott A OakesDepartment of Pathology, The University of Chicago, Chicago, IL.
Søren S OlesenDepartment of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
Edward A PhelpsJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.
Alvin C PowersDepartment of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN.
Cherie L StablerJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.
Temel TirkesDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN.
David C WhitcombDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA.
Dhiraj YadavDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA.
Jing YongDegenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Norann A ZaghloulNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Stephen J PandolDepartment of Pediatrics and Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA.
Maike SanderDepartment of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA.

Funding

TARGETS FOR SCREENING IN PANCREATIC NEOPLASIAP50CA062924 · JOHNS HOPKINS UNIVERSITY · 1993 to 2005
$17.4M
TRANSGENIC COREP60DK020595 · UNIVERSITY OF CHICAGO · 1985 to 2005
$11.9M
Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · 1997 to 2025
$11.1M
Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1DU01DK112217 · UNIVERSITY OF PENNSYLVANIA · 2025 to 2025
$9.0M
Pilot & Feasibility ProgramP30DK063491 · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2003 to 2025
$5.4M
Interferon Signaling in the T1D Islet MicroenvironmentU01DK127786 · UNIVERSITY OF CHICAGO · 2025 to 2025
$3.5M
Multi-omic 3D tissue maps for a Human BioMolecular AtlasU54DK127823 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI MARTHA CAMPBELL-THOMPSON, James Paul Carson · 2023 to 2023
$2.6M
Vanderbilt Diabetes Research CenterP30DK020593 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$1.8M
Mechanism and dynamics of islet GABA signalingR01DK124267 · NIDDK · UNIVERSITY OF FLORIDA · 2022 to 2025
$1.4M
Role of IGF-1 and insulin receptors beta-cell survivalR01DK067536 · JOSLIN DIABETES CENTER · 2004 to 2025
$1.4M
Physiology CoreP30DK020595 · UNIVERSITY OF CHICAGO · 2025 to 2025
$1.4M
BLRD VA I01 BX000666BLRD VA I01 BX002728NCATS NIH HHS UL1 TR001863NCI NIH HHS DP2 CA248136NCI NIH HHS P50 CA062924NCI NIH HHS R01 CA154823NCI NIH HHS R01 CA219815NCI NIH HHS R01 CA260955NCI NIH HHS U01 CA247283NEI NIH HHS R01 EY027810NHGRI NIH HHS U01 HG012059NIAID NIH HHS P01 AI042288NIDDK NIH HHS F31 DK130607NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P30 DK063491NIDDK NIH HHS P30 DK089507NIDDK NIH HHS P30 DK117467NIDDK NIH HHS P60 DK020595NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK068471NIDDK NIH HHS R01 DK073716NIDDK NIH HHS R01 DK078803NIDDK NIH HHS R01 DK080834NIDDK NIH HHS R01 DK114427NIDDK NIH HHS R01 DK117192NIDDK NIH HHS R01 DK121987NIDDK NIH HHS R01 DK122160NIDDK NIH HHS R01 DK122167NIDDK NIH HHS R01 DK122607NIDDK NIH HHS R01 DK123329NIDDK NIH HHS R01 DK124267NIDDK NIH HHS R01 DK132103NIDDK NIH HHS R01 DK133183NIDDK NIH HHS R56 DK067536NIDDK NIH HHS U01 DK108306NIDDK NIH HHS U01 DK108314NIDDK NIH HHS U01 DK108323NIDDK NIH HHS U01 DK112217NIDDK NIH HHS U01 DK120429NIDDK NIH HHS U01 DK120456NIDDK NIH HHS U01 DK123716NIDDK NIH HHS U01 DK126300NIDDK NIH HHS U01 DK127367NIDDK NIH HHS U01 DK127377NIDDK NIH HHS U01 DK127382NIDDK NIH HHS U01 DK127392NIDDK NIH HHS U01 DK127403NIDDK NIH HHS U01 DK127786NIDDK NIH HHS U01 DK135095NIDDK NIH HHS U54 DK127823NIDDK NIH HHS UC4 DK112217NIDDK NIH HHS UG3 DK122639NIDDK NIH HHS UH3 DK122638
6 · The paper itself

Abstract

The Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases workshop was a 1.5-day scientific conference at the National Institutes of Health (Bethesda, MD) that engaged clinical and basic science investigators interested in diseases of the pancreas. This report provides a summary of the proceedings from the workshop. The goals of the workshop were to forge connections and identify gaps in knowledge that could guide future research directions. Presentations were segregated into six major theme areas, including 1) pancreas anatomy and physiology, 2) diabetes in the setting of exocrine disease, 3) metabolic influences on the exocrine pancreas, 4) genetic drivers of pancreatic diseases, 5) tools for integrated pancreatic analysis, and 6) implications of exocrine-endocrine cross talk. For each theme, multiple presentations were followed by panel discussions on specific topics relevant to each area of research; these are summarized here. Significantly, the discussions resulted in the identification of research gaps and opportunities for the field to address. In general, it was concluded that as a pancreas research community, we must more thoughtfully integrate our current knowledge of normal physiology as well as the disease mechanisms that underlie endocrine and exocrine disorders so that there is a better understanding of the interplay between these compartments.

Indexed as

Diabetes MellitusIslets of LangerhansPancreas, ExocrinePancreatic DiseasesHumansPancreas

Identifiers

PMID36940317
PMCPMC10033248

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.